STAT3 inhibitor containing quinolinecarboxamide derivative as active ingredient
申请人:Asai Akira
公开号:US08466290B2
公开(公告)日:2013-06-18
The present invention provides a STATS inhibitor containing as an active ingredient, a quinolinecarboxamide derivative represented by the formula (I) (in the formula, W represents a bond or an alkylene chain; X represents O, S, or NR34; and R1 to R8 and R34 each represent H, halogen, alkyl, phenyl, furyl, thienyl, or the like), or a pharmacologically acceptable salt thereof.
STAT3 INHIBITOR CONTAINING QUINOLINECARBOXAMIDE DERIVATIVE AS ACTIVE INGREDIENT
申请人:General Incorporated Association Pharma Valley
Project Supporting Organization
公开号:EP2325181B1
公开(公告)日:2017-03-29
2(5-Nitro-2-thienyl)cinchoninic acids
作者:Iradj Lalezari、F. Ghabgharan、R. Maghsoudi
DOI:10.1021/jm00287a031
日期:1971.5
US8466290B2
申请人:——
公开号:US8466290B2
公开(公告)日:2013-06-18
Synthesis and pharmacological properties of some quinoline derivatives
作者:Balakrishna Kalluraya、S. Sreenivasa
DOI:10.1016/s0014-827x(98)00037-8
日期:1998.6
confirmed by analytical, IR, NMR and mass spectral data. The newly synthesized compounds were evaluated for their anti-inflammatory, analgesic and anthelmintic activity. The results indicated that dinitrothiophene derivatives 5 are more active.